Company Data
Beam Therapeutics Inc.
Ticker
BEAM
Current Price
$33.14 -2.79%
Market Cap
$2.7B
Price Target
Refer to Report
Volume
1.3M
52wk Range
$20.84 - $49.5
Overview
Beam Therapeutics Inc is a biotechnology company engaged in creating genetic medicines based on its base editing technology. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the DNA. The company’s portfolio comprises Gene Correction, Gene Modification, Gene Activation, Gene Silencing, and Multiplex Editing.